Clinical Trials Browser

Interventional × Urinary Bladder Neoplasms × enzalutamide × Clear all

Lethal Congenital Contracture Syndrome 2, Fibromatosis, Gingival, 2, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Endometrial Neoplasms, Prostatic Neoplasms, Castration-Resistant, Triple Negative Breast Neoplasms

NCT02300610 2019-08-01

Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer

Phase 1 Completed

10 enrolled 14 charts

Genitourinary

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Carcinoma, Carcinoma, Transitional Cell, Ureteral Diseases, Ureteral Neoplasms, Urethral Neoplasms

NCT02605863 2018-10-03

Enzalutamide for Bladder Cancer Chemoprevention

Phase 2 Terminated

1 enrolled 6 charts

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Clinical Trials

A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours

Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer

Enzalutamide for Bladder Cancer Chemoprevention